Australian health authorities are holding urgent talks on the use of the AstraZeneca vaccine after the European medical bodies issued warnings over the vaccine’s link to blood clots.
On Wednesday, the European Medicines Authority (EMA) said blood-clotting should be listed as a “very rare” side effect of taking the jab, while also noting that women and people under 60 were at higher risks of developing the symptoms. The statement came after the drug regulator received reports of 169 cases of a rare blood clot in people who got AstraZeneca’s COVID-19 vaccine.
